Your browser doesn't support javascript.
COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients.
Sienko, Jerzy; Kotowski, Maciej; Bogacz, Anna; Lechowicz, Kacper; Drozdzal, Sylwester; Rosik, Jakub; Sietnicki, Marek; Sienko, Magdalena; Kotfis, Katarzyna.
  • Sienko J; Department of General Surgery and Transplantology, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Kotowski M; Department of General Surgery and Transplantology, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Bogacz A; Department of Pharmacology and Phytochemistry, Institute of Natural Fibers and Medicinal Plants, Poznan, Poland.
  • Lechowicz K; Department of Anaesthesiology, Intensive Therapy and Acute Intoxications, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Drozdzal S; Department of Pharmacokinetics and Monitored Therapy, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Rosik J; Department of Physiology, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Sietnicki M; Department of Civil Engineering and Architecture, West Pomeranian University of Technology in Szczecin, Szczecin, Poland.
  • Sienko M; Department of Pediatrics, Endocrinology, Diabetology, Metabolic Diseases and Cardiology, Pomeranian Medical University in Szczecin, Szczecin, Poland.
  • Kotfis K; Department of Anaesthesiology, Intensive Therapy and Acute Intoxications, Pomeranian Medical University in Szczecin, Szczecin, Poland.
Clin Interv Aging ; 15: 1231-1240, 2020.
Article in English | MEDLINE | ID: covidwho-689982
ABSTRACT
Since the beginning of 2020, the whole world has been struggling with the pandemic of Coronavirus Disease 2019 (COVID-19) caused by a novel coronavirus SARS-CoV-2. The SARS-CoV-2 infection depends on ACE2, TMPRSS2, and CD147, which are expressed on host cells. Several studies suggest that some single nucleotide polymorphisms (SNPs) of ACE2 might be a risk factor of COVID-19 infection. Genotypes affect ACE2 structure, its serum concentration, and levels of circulating angiotensin (1-7). Moreover, there is evidence that ACE genotype affects the outcomes of acute respiratory distress syndrome (ARDS) treatment, the most severe consequence of SARS-CoV-2 infection. COVID-19 morbidity, infection course, and mortality might depend on ACE D allele frequency. The aim of this narrative review was to analyze and identify the mechanisms of ACE-I and ARBs with particular emphasis on angiotensin receptors and their polymorphism in the light of COVID-19 pandemic as these medications are commonly prescribed to elderly patients. There is no direct evidence yet for ACE-I or ARBs in the treatment of COVID-19. However, for those already taking these medications, both the European Society of Cardiology and the American College of Cardiology recommend continuing the treatment, because at present, there is no clear clinical or scientific evidence to justify the discontinuation of ACE-I or ARBs. Individualized treatment decisions should be based on the clinical condition and co-morbidities of each patient.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Betacoronavirus Type of study: Prognostic study / Reviews Limits: Aged / Animals / Humans Language: English Journal: Clin Interv Aging Journal subject: Geriatrics Year: 2020 Document Type: Article Affiliation country: CIA.S261516

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Betacoronavirus Type of study: Prognostic study / Reviews Limits: Aged / Animals / Humans Language: English Journal: Clin Interv Aging Journal subject: Geriatrics Year: 2020 Document Type: Article Affiliation country: CIA.S261516